Granite Point Capital Management, L.P.

Holdings History for TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM)

Symbol: TNDM on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2023		2.2%	+2.2%	$609,150	15,000	+15,000	NEW	$40.61	Q1 2023
30 Jun 2022			-1.5%	$0	0	-25,366	-100%	$19.17	Q2 2022
31 Mar 2022		1.5%	-0.37%	$2,950,000	25,366	-6,342	-20%	$116.30	Q1 2022
31 Dec 2021		1.9%	+0.82%	$4,773,000	31,708	+14,000	+79%	$150.53	Q4 2021
30 Sep 2021		0.82%	0%	$2,114,000	17,708	0		$119.38	Q3 2021
30 Jun 2021		0.51%	0%	$1,725,000	17,708	0		$97.41	Q2 2021
31 Mar 2021		0.46%	-0.32%	$1,563,000	17,708	-12,292	-41%	$88.27	Q1 2021
31 Mar 2021	call		-0.45%	$0	0	-75,000	-100%	$19.17	Q1 2021
31 Dec 2020		0.9%	0%	$2,870,000	30,000	0		$95.67	Q4 2020
31 Dec 2020	call	0.45%	+0.33%	$7,176,000	75,000	+55,000	+275%	$95.68	Q4 2020
30 Sep 2020		1.4%	-2.1%	$3,405,000	30,000	-45,300	-60%	$113.50	Q3 2020
30 Sep 2020	call	0.14%	-0.57%	$2,270,000	20,000	-80,000	-80%	$113.50	Q3 2020
30 Jun 2020		3.1%	-1.2%	$7,449,000	75,300	-29,700	-28%	$98.92	Q2 2020
30 Jun 2020	call	0.57%	+0.57%	$9,892,000	100,000	+100,000	NEW	$98.92	Q2 2020
31 Mar 2020		4.9%	+3%	$6,757,000	105,000	+65,000	+162%	$64.35	Q1 2020
31 Dec 2019		1.8%	-0.09%	$2,384,000	40,000	-2,000	-4.8%	$59.60	Q4 2019
30 Sep 2019		2.3%	+0.55%	$2,477,000	42,000	+10,000	+31%	$58.98	Q3 2019
30 Jun 2019		1.5%	-2%	$2,065,000	32,000	-43,000	-57%	$64.53	Q2 2019
31 Mar 2019		2.9%	-0.95%	$4,763,000	75,000	-25,000	-25%	$63.51	Q1 2019
31 Mar 2019	call		-0.98%	$0	0	-100,000	-100%	$19.17	Q1 2019
31 Dec 2018		3.5%	-1.4%	$3,797,000	100,000	-40,000	-29%	$37.97	Q4 2018
31 Dec 2018	call	0.98%	-1.5%	$3,797,000	100,000	-150,000	-60%	$37.97	Q4 2018
30 Sep 2018		3.4%	-2.1%	$5,998,000	140,000	-85,000	-38%	$42.84	Q3 2018
30 Sep 2018	call	0.8%	+0.8%	$10,710,000	250,000	+250,000	NEW	$42.84	Q3 2018
30 Jun 2018		2.4%	+2.4%	$4,955,000	225,000	+225,000	NEW	$22.02	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.